The UK MHRA has just approved the very first oral GLP-1 medication for weight management, marking a revolutionary breakthrough in obesity treatment. This cutting-edge option offers patients an easy and convenient alternative to injections, transforming the way weight loss is approached
Brazil has just approved its very first generic semaglutide pen, a groundbreaking moment following the expiration of the Ozempic patent. This exciting development opens the door to more affordable and accessible diabetes treatments, Reuters reports
Apotex is transforming osteoporosis care across Canada with Health Canada's green light for DENOZA™, a cutting-edge denosumab biosimilar. This thrilling launch promises to make treatment more accessible and affordable for patients everywhere!
